4-butyrolactone has been researched along with Acute Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gotoh, N; Ishii, K; Kamimatsuno, R; Kanno, E; Kawakami, K; Maruyama, R; Miyairi, S; Miyasaka, T; Suzuki, A; Tachi, M; Takagi, N; Tanno, H | 1 |
| Duketis, E; Holtmann, M; Maier, J; Poustka, F; Radeloff, D; Schirman, S; Wagner, A; Wöckel, L; Zepf, FD | 1 |
| Barie, PS; Cohen, SM; Darakchiev, B; Fantini, GA; Hariri, RJ; Siddiqi, FA | 1 |
| Alcaraz, MJ; De Giulio, A; De Rosa, S; García Pastor, P; Payá, M | 1 |
1 review(s) available for 4-butyrolactone and Acute Disease
| Article | Year |
|---|---|
[Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists].
Topics: 4-Butyrolactone; Acute Disease; Adolescent; Anesthetics, Intravenous; Antipsychotic Agents; Benzodiazepines; Butylene Glycols; Child; Critical Care; Delusions; Diagnosis, Differential; Drug Interactions; Humans; Psychoses, Substance-Induced; Sodium Oxybate; Substance Withdrawal Syndrome; Substance-Related Disorders | 2009 |
3 other study(ies) available for 4-butyrolactone and Acute Disease
| Article | Year |
|---|---|
Promotion of acute-phase skin wound healing by Pseudomonas aeruginosa C
Topics: 4-Butyrolactone; Acute Disease; Analysis of Variance; Animals; Biopsy, Needle; Disease Models, Animal; Female; Homoserine; Immunohistochemistry; Neutrophils; Pseudomonas aeruginosa; Random Allocation; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Tumor Necrosis Factor-alpha; Wound Healing; Wounds and Injuries | 2016 |
Attenuation of acute lung injury caused by hind-limb ischemia-reperfusion injury by butyrolactone anti-inflammatory agent FL1003.
Topics: 4-Butyrolactone; Acute Disease; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Capillary Permeability; Disease Models, Animal; Drug Evaluation, Preclinical; Extravascular Lung Water; Hindlimb; Lipid Peroxidation; Lung; Lung Injury; Male; Organ Size; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 1997 |
Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2.
Topics: 4-Butyrolactone; Acute Disease; Animals; Anti-Infective Agents; Arthritis, Experimental; Chronic Disease; Dose-Response Relationship, Drug; Ear; Edema; Enzymes; Female; Humans; Inflammation; Leukocytes; Male; Mice; Phospholipases A; Phospholipases A2; Pyrans; Rats; Rats, Wistar; Synovial Fluid; U937 Cells | 1999 |